Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant Prostate Cancer

Document Details

Document Type
Pub Defense Publication
Publication Date
Jan 01, 2020
Source ID
10.1016/j.eururo.2019.05.032

Entities

People

  • Catherine H. Marshall
  • Channing J Paller
  • Emmanuel S. Antonarakis
  • Fabiola A.s. Lima
  • Fahad Qazi
  • Farah Shaukat
  • Hao Wang
  • Mario A. Eisenberger
  • Mark C Markowski
  • Michael A. Carducci
  • Nooshin Mirkheshti
  • Pedro Isaacsson Velho
  • Samuel Denmeade
  • Wei Fu

Organizations

  • National Institutes of Health
  • United States Department of Defense